|
|
||||||||
German Diabetes Research Institute, University of Dusseldorf, Dusseldorf, Germany
The cholera toxin B chain (CTB) has been reported to suppress T
cell-dependent autoimmune diseases and to potentiate tolerance of the
adaptive immune system. We have analyzed the effects of CTB on
macrophages in vitro and have found that preincubation with CTB (10
µg/ml) suppresses the proinflammatory reaction to LPS challenge, as
demonstrated by suppressed production of TNF-
, IL-6, IL-12(p70), and
NO (p < 0.01) in cells of macrophage lines.
Pre-exposure to CTB also suppresses LPS-induced TNF-
and IL-12(p70)
formation in human PBMC. Both native and recombinant CTB exhibited
suppressive activity, which was shared by intact cholera toxin. In
cells of the human monocyte line Mono Mac 6, exposure to CTB failed to
suppress the production of IL-10 in response to LPS. Control
experiments excluded a role of possible contamination of CTB by
endotoxin or intact cholera toxin. The suppression of TNF-
production occurred at the level of mRNA formation. Tolerance induction
by CTB was dose and time dependent. The suppression of TNF-
and IL-6
production could be counteracted by the addition of Abs to IL-10 and
TGF-
. IFN-
also antagonized the actions of CTB on macrophages. In
contrast to desensitization by low doses of LPS, tolerance induction by
CTB occurred silently, i.e., in the absence of a measurable
proinflammatory response. These findings identify immune-deviating
properties of CTB at the level of innate immune cells and may be
relevant to the use of CTB in modulating immune-mediated
diseases.
This article has been cited by other articles:
![]() |
A. D'Ambrosio, M. Colucci, O. Pugliese, F. Quintieri, and M. Boirivant Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation J. Leukoc. Biol., September 1, 2008; 84(3): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Schnitzler, J. M. Burke, and L. M. Wetzler Induction of Cell Signaling Events by the Cholera Toxin B Subunit in Antigen-Presenting Cells Infect. Immun., June 1, 2007; 75(6): 3150 - 3159. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Skurk, C. Herder, I. Kraft, S. Muller-Scholze, H. Hauner, and H. Kolb Production and Release of Macrophage Migration Inhibitory Factor from Human Adipocytes Endocrinology, March 1, 2005; 146(3): 1006 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Lavelle, A. Jarnicki, E. McNeela, M. E. Armstrong, S. C. Higgins, O. Leavy, and K. H. G. Mills Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent J. Leukoc. Biol., May 1, 2004; 75(5): 756 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lindholm, A. Naylor, E.-L. Johansson, and M. Quiding-Jarbrink Mucosal Vaccination Increases Endothelial Expression of Mucosal Addressin Cell Adhesion Molecule 1 in the Human Gastrointestinal Tract Infect. Immun., February 1, 2004; 72(2): 1004 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Yadav, Z. Liu, and M. M. Rafi A Diarylheptanoid from Lesser Galangal (Alpinia officinarum) Inhibits Proinflammatory Mediators via Inhibition of Mitogen-Activated Protein Kinase, p44/42, and Transcription Factor Nuclear Factor-{kappa}B J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Cavaillon, C. Adrie, C. Fitting, and M. Adib-Conquy Endotoxin tolerance: is there a clinical relevance? Innate Immunity, April 1, 2003; 9(2): 101 - 107. [Abstract] [PDF] |
||||
![]() |
P. Chen, J. Li, J. Barnes, G. C. Kokkonen, J. C. Lee, and Y. Liu Restraint of Proinflammatory Cytokine Biosynthesis by Mitogen-Activated Protein Kinase Phosphatase-1 in Lipopolysaccharide-Stimulated Macrophages J. Immunol., December 1, 2002; 169(11): 6408 - 6416. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Bagley, S. F. Abdelwahab, R. G. Tuskan, T. R. Fouts, and G. K. Lewis Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway Infect. Immun., October 1, 2002; 70(10): 5533 - 5539. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |